HIV therapy: managing resistance (Q36104156)

12 August 2017

HIV therapy: managing resistance (English)

1 reference

12 August 2017

D Wodarz

1

1 reference

PMCID

34002

12 August 2017

M A Nowak

series ordinal

2

1 reference

PMCID

34002

12 August 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

Proceedings of the National Academy of Sciences of the United States of America

12 August 2017

3

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

12 August 2017

97

1 reference

12 August 2017

15

1 reference

12 August 2017

8193-8195

1 reference

Production of resistant HIV mutants during antiretroviral therapy

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

Adherence and drug resistance: predictions for therapy outcome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

Adherence to combination antiretroviral therapy: synthesis of the literature and clinical implications

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

The role of antigen-independent persistence of memory cytotoxic T lymphocytes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

Strategies for long-term success in the treatment of HIV infection

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

Specific therapy regimes could lead to long-term immunological control of HIV.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

Drug concentration heterogeneity facilitates the evolution of drug resistance.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

Virus dynamics and drug therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

Clinical data sets of human immunodeficiency virus type 1 reverse transcriptase-resistant mutants explained by a mathematical model.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

Drug resistance in viruses

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

Population dynamics of HIV within an individual after treatment with zidovudine.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

Resistance, fitness, adherence, and potency: mapping the paths to virologic failure.

2 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.15.8193

Pre-existence and emergence of drug resistance in HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.15.8193

Different outcomes in patients achieving complete or partial viral load suppression on antiretroviral therapy.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

Quasispecies dynamics and the emergence of drug resistance during zidovudine therapy of HIV infection.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34002

Control of HIV despite the Discontinuation of Antiretroviral Therapy

23 September 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.15.8193

Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.15.8193

21 January 2018

Identifiers

DOI

10.1073/PNAS.97.15.8193

1 reference

12 August 2017

0 references

1 reference

12 August 2017

1 reference

PMCID

34002